A detailed history of Waddell & Associates, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Waddell & Associates, LLC holds 6,166 shares of JNJ stock, worth $955,976. This represents 0.12% of its overall portfolio holdings.

Number of Shares
6,166
Previous 5,938 3.84%
Holding current value
$955,976
Previous $867,000 15.22%
% of portfolio
0.12%
Previous 0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$145.48 - $167.38 $33,169 - $38,162
228 Added 3.84%
6,166 $999,000
Q2 2024

Aug 06, 2024

BUY
$144.38 - $157.78 $49,089 - $53,645
340 Added 6.07%
5,938 $867,000
Q1 2024

May 08, 2024

SELL
$155.22 - $162.74 $12,728 - $13,344
-82 Reduced 1.44%
5,598 $885,000
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $465,192 - $507,621
-3,195 Reduced 36.0%
5,680 $890,000
Q3 2023

Nov 07, 2023

SELL
$155.75 - $174.48 $61,365 - $68,745
-394 Reduced 4.25%
8,875 $1.38 Million
Q2 2023

Aug 07, 2023

BUY
$154.35 - $166.11 $23,306 - $25,082
151 Added 1.66%
9,269 $1.53 Million
Q1 2023

May 10, 2023

SELL
$151.05 - $180.26 $38,366 - $45,786
-254 Reduced 2.71%
9,118 $1.41 Million
Q4 2022

Feb 09, 2023

BUY
$160.2 - $179.79 $19,544 - $21,934
122 Added 1.32%
9,372 $1.66 Million
Q3 2022

Nov 02, 2022

SELL
$161.33 - $179.52 $79,697 - $88,682
-494 Reduced 5.07%
9,250 $1.51 Million
Q2 2022

Jul 27, 2022

BUY
$168.19 - $186.01 $81,235 - $89,842
483 Added 5.22%
9,744 $1.73 Million
Q1 2022

Apr 21, 2022

SELL
$158.14 - $179.59 $8,065 - $9,159
-51 Reduced 0.55%
9,261 $1.64 Million
Q4 2021

Feb 01, 2022

SELL
$155.93 - $173.01 $2,806 - $3,114
-18 Reduced 0.19%
9,312 $1.59 Million
Q3 2021

Nov 10, 2021

BUY
$161.5 - $179.47 $835,924 - $928,936
5,176 Added 124.6%
9,330 $1.51 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $662,479 - $710,624
4,154 New
4,154 $684,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Waddell & Associates, LLC Portfolio

Follow Waddell & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waddell & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waddell & Associates, LLC with notifications on news.